Pyroptosis-based nanotherapeutics: Possible mechanisms for cancer treatment

Veda Muppala, Batoul Farran, Ganji Purnachandra Nagaraju

Research output: Contribution to journalReview articlepeer-review

Abstract

Pyroptosis represents an inflammatory cell death form induced by inflammasomes and performed by gasdermins. It is characterized by swelling, pore formation, release of cellular content and the activation of innate immunity leading to inflammation. Hence, pyroptosis contributes to inflammatory conditions like cancer and has emerged as a promising immuno-strategy for treating cancer. The advent of nanotechnology, which overlaps with the discovery of pyroptotic cell death, has enabled the development of nano-based pyroptosis inducing platforms aimed at overcoming resistance to apoptosis and enhancing tumor immunity. In this paper, we will describe the various molecular pathways underlying pyroptosis, such as canonical and non-canonical pyroptosis. We will then explore the advances in the field of pyroptosis-based nanotherapeutics and their future implications.

Original languageEnglish (US)
Article number120970
JournalLife Sciences
Volume308
DOIs
StatePublished - Nov 1 2022

Keywords

  • Inflammasomes
  • Nanotechnology
  • Pyroptosis
  • Therapy
  • cancer

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint

Dive into the research topics of 'Pyroptosis-based nanotherapeutics: Possible mechanisms for cancer treatment'. Together they form a unique fingerprint.

Cite this